317 related articles for article (PubMed ID: 32542847)
1. Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities.
Al-Riyami AZ; Schäfer R; van den Berg K; Bloch EM; Estcourt LJ; Goel R; Hindawi S; Josephson CD; Land K; McQuilten ZK; Spitalnik SL; Wood EM; Devine DV; So-Osman C
Vox Sang; 2021 Jan; 116(1):88-98. PubMed ID: 32542847
[TBL] [Abstract][Full Text] [Related]
2. Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility.
Al-Riyami AZ; Estcourt L; Rahimi-Levene N; Bloch EM; Goel R; Tiberghien P; Thibert JB; Bruun MT; Devine DV; Gammon RR; Wendel S; Toungouz Nevessignsky M; Grubovic Rastvorceva RM; Oreh A; Romon I; van den Berg K; Kitazawa J; Patidar G; So-Osman C; Wood EM;
Vox Sang; 2022 Oct; 117(10):1202-1210. PubMed ID: 36102139
[TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma in hospitalized pediatric and obstetric coronavirus disease 2019 (COVID-19) patients.
Ikeda S; Benzi E; Hensch LA; Devaraj S; Hui SR; Gandhi M; Fox KA; Teruya J; Munoz FM
Pediatr Int; 2022 Jan; 64(1):e15407. PubMed ID: 36326636
[TBL] [Abstract][Full Text] [Related]
4. COVID 19 convalescent plasma: Is there still a place for CCP?
Moog R
Transfus Apher Sci; 2023 Apr; 62(2):103680. PubMed ID: 36870907
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional experience with COVID-19 convalescent plasma in children.
Jacquot C; Gordon O; Noland D; Donowitz JR; Levy E; Jain S; Willis Z; Rimland C; Loi M; Arrieta A; Annen K; Drapeau N; Osborne S; Ardura MI; Arora S; Zivick E; Delaney M
Transfusion; 2023 May; 63(5):918-924. PubMed ID: 36965173
[TBL] [Abstract][Full Text] [Related]
6. Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.
Bloch EM; Goel R; Wendel S; Burnouf T; Al-Riyami AZ; Ang AL; DeAngelis V; Dumont LJ; Land K; Lee CK; Oreh A; Patidar G; Spitalnik SL; Vermeulen M; Hindawi S; Van den Berg K; Tiberghien P; Vrielink H; Young P; Devine D; So-Osman C
Vox Sang; 2021 Jan; 116(1):18-35. PubMed ID: 32533868
[TBL] [Abstract][Full Text] [Related]
7. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
Bégin P; Callum J; Heddle NM; Cook R; Zeller MP; Tinmouth A; Fergusson DA; Cushing MM; Glesby MJ; Chassé M; Devine DV; Robitalle N; Bazin R; Shehata N; Finzi A; McGeer A; Scales DC; Schwartz L; Turgeon AF; Zarychanski R; Daneman N; Carl R; Amorim L; Gabe C; Ellis M; Sachais BS; Loftsgard KC; Jamula E; Carruthers J; Duncan J; Lucier K; Li N; Liu Y; Armali C; Kron A; Modi D; Auclair MC; Cerro S; Avram M; Arnold DM
Trials; 2021 May; 22(1):323. PubMed ID: 33947446
[TBL] [Abstract][Full Text] [Related]
8. Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.
Huaman MA; Raval JS; Paxton JH; Mosnaim GS; Patel B; Anjan S; Meisenberg BR; Levine AC; Marshall CE; Yarava A; Shenoy AG; Heath SL; Currier JS; Fukuta Y; Blair JE; Spivak ES; Petrini JR; Broderick PB; Rausch W; Cordisco M; Hammel J; Greenblatt B; Cluzet VC; Cruser D; Oei K; Abinante M; Hammitt LL; Sutcliffe CG; Forthal DN; Zand MS; Cachay ER; Kassaye SG; Ram M; Wang Y; Das P; Lane K; McBee NA; Gawad AL; Karlen N; Ford DE; Laeyendecker O; Pekosz A; Klein SL; Ehrhardt S; Lau B; Baksh SN; Shade DM; Casadevall A; Hanley DF; Ou J; Gniadek TJ; Ziman A; Shoham S; Gebo KA; Bloch EM; Tobian AAR; Sullivan DJ; Gerber JM
Transfusion; 2023 Sep; 63(9):1639-1648. PubMed ID: 37534607
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
10. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
11. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
12. Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic.
Wendel S; Land K; Devine DV; Daly J; Bazin R; Tiberghien P; Lee CK; Arora S; Patidar GK; Khillan K; Smid WM; Vrielink H; Oreh A; Al-Riyami AZ; Hindawi S; Vermeulen M; Louw V; Burnouf T; Bloch EM; Goel R; Townsend M; So-Osman C
Vox Sang; 2021 Sep; 116(8):872-879. PubMed ID: 33772791
[TBL] [Abstract][Full Text] [Related]
13. High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
De Santis GC; Oliveira LC; Garibaldi PMM; Almado CEL; Croda J; Arcanjo GGA; Oliveira ÉAF; Tonacio AC; Langhi DM; Bordin JO; Gilio RN; Palma LC; Santos EV; Haddad SK; Prado BPA; Pontelli MC; Gomes R; Miranda CH; Auxiliadora Martins M; Covas DT; Arruda E; Fonseca BAL; Calado RT
Emerg Infect Dis; 2022 Mar; 28(3):548-555. PubMed ID: 35081022
[TBL] [Abstract][Full Text] [Related]
14. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
Bloch EM; Goel R; Montemayor C; Cohn C; Tobian AAR
Transfus Apher Sci; 2021 Feb; 60(1):102957. PubMed ID: 32972861
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
Alsharidah S; Ayed M; Ameen RM; Alhuraish F; Rouheldeen NA; Alshammari FR; Embaireeg A; Almelahi M; Adel M; Dawoud ME; Aljasmi MA; Alshammari N; Alsaeedi A; Al-Adsani W; Arian H; Awad H; Alenezi HA; Alzafiri A; Gouda EF; Almehanna M; Alqahtani S; Alshammari A; Askar MZ
Int J Infect Dis; 2021 Feb; 103():439-446. PubMed ID: 33285283
[TBL] [Abstract][Full Text] [Related]
16. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.
Yokoyama APH; Wendel S; Bonet-Bub C; Fachini RM; Dametto APF; Blumm F; Dutra VF; Candelaria GTP; Sakashita AM; Machado RRG; Fontão-Wendel R; Hamerschlak N; Achkar R; Assunção MSC; Scuracchio P; Nudelman V; Pastore L; Pinho JRR; Ben MD; Filho RK; Marra AR; Amano MT; Kallás EG; Helito AS; de Carvalho CRR; Araujo DB; Durigon EL; Camargo AA; Rizzo LV; Reis LFL; Kutner JM
Transfusion; 2021 Aug; 61(8):2295-2306. PubMed ID: 34173248
[TBL] [Abstract][Full Text] [Related]
18. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
Estcourt LJ; Cohn CS; Pagano MB; Iannizzi C; Kreuzberger N; Skoetz N; Allen ES; Bloch EM; Beaudoin G; Casadevall A; Devine DV; Foroutan F; Gniadek TJ; Goel R; Gorlin J; Grossman BJ; Joyner MJ; Metcalf RA; Raval JS; Rice TW; Shaz BH; Vassallo RR; Winters JL; Tobian AAR
Ann Intern Med; 2022 Sep; 175(9):1310-1321. PubMed ID: 35969859
[TBL] [Abstract][Full Text] [Related]
19. Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds.
Larkey NE; Ewaisha R; Lasho MA; Roforth MM; Granger D; Jerde CR; Wu L; Gorsh A; Klassen SA; Senefeld JW; Joyner MJ; Baumann NA; Theel ES; Mills JR
Microbiol Spectr; 2022 Aug; 10(4):e0115422. PubMed ID: 35862939
[TBL] [Abstract][Full Text] [Related]
20. Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma.
Swenson E; Wong LK; Jhaveri P; Weng Y; Kappagoda S; Pandey S; Pritchard A; Rogers A; Ruoss S; Subramanian A; Shan H; Hollenhorst M
Transfusion; 2022 Jan; 62(1):28-36. PubMed ID: 34677830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
